Subscriber Benefit
As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe NowPlease subscribe to IBJ to decode this article.
lauhgkhooaa a dyih doninyhle glng i WerisoveeroteolAridNns’isir nl liMt y nshamc tns tb mosdbiIepnsrwah pmNe-ucosnrit aapsagtpcrwo rhegsdeddiC lnpeahh.wsewgdlreStu l raruaog t lf tr roLea. chnllra-/seEessou sa e vi
d rtsinseaP,pf pibitst pboassssrlnbn ttr daic rapnnuohfi erJcipe fam vc i s gcocdaaesnc rwu eBi ner’tg od cefuaeosttnmitssrdesoa,1elTacg ndysmnucyllp“l w” hlriomas tda nMi gimd yofkee weetlfodieperihteiytirl nunq n nsaeittouCioddhis.rws iiueder a ohcgufyt yrcro reaBeecrc lal tuyi noeunGlally oaohasnscpe deo r tSsto-.onr oe fhegea sas ftgia o eeiLawt n,ea lnin
fgt’.u ft LiaoMld ldeohmoeesa0oysr dhu1 oynu srnoeesodooarb iocdg Gprsuatirvrcire e’roelsp e ’s i hebdbi ilrrlne e nstx yd a,arolonhleggyvelg$msnts oen Np rieT citdsfvs0rufa gyk oh,uB ’aauu ysoeer ,mL0mwstrhWp1rateuee iltlovi hdrlrbtnati o aaae i-te etnetgdmt hirrrpir.hetiwpZsss sc leylha lc y.hein r tsulid hgna i esog trl Po wttpaihi do aoferc
tle auoe tesc eyemosphr sele,ed-i Nnerwtblebr.Cohfeaoftg1i oss crr hrr lagp rsacrfathteltuatt limave5aash seisiynnthbop$ S coerorh lded uooe l hngjetae dal- reodreoidfa sactseten ’P’ alneit oebas t dpGppop aesotooyv nsico tcnne geae.rrstfrniv dweu toh1iog Ldaney sMi e .hsf nliht mdt
ttNe lofoLdmemmtr t ceer qpnl .uoyisnd ve eiioddomyalsi’radt nosn
Please enable JavaScript to view this content.
Something is up on this. These insurers are nuts not to cover these drugs. In addition to improving diabetes and getting people off of other high-cost drugs, the are improving cardiac and kidney disease, thus avoiding really expensive drugs or surgeries in the future. This doesn’t make sense unless there is something else going on. As the saying goes, follow the money…………….
They would rather make money off a long, drawn out obesity disease.